Back to News
Market Impact: 0.25
Amgen Drops 10% on a Trial It Didn't Even Run
Source: marketbeat.com
Corporate EarningsHealthcare & Biotech
Amgen delivered a strong earnings report on Aug. 4, according to the article. No revenue, EPS, guidance, or other financial magnitudes were provided to assess the extent of the earnings outperformance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
AMGN0.65
More News
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Surging cloud revenue boosted Oracle’s quarterly results. Here’s what analysts are saying
- Oracle jumps 6% after reporting 30% revenue growth fueled by AI cloud demand
- Apollo Global in talks to acquire J&J’s orthopedics unit, Bloomberg News reports
- Oracle’s AI Cloud Growth Eases Buildout Concerns
- U.S. CPI looms large; Oracle, Adobe report - what’s moving markets